Tenax Therapeutics Inc news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

TENX 3.68 -0.01 (-0.27%)
price chart
Company Shares of Tenax Therapeutics, Inc. Rally 1.36%
Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX) appreciated by 1.36% during the past week but lost 0.93% on a 4-week basis.
Oxygen Biotherapeutics Announces Name Change to Tenax Therapeutics
Tenax Therapeutics, Inc., is a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market.
Related articles »  
Tenax Therapeutics to Provide Corporate Update and Discuss Fourth Quarter and ...
MORRISVILLE, N.C., Jul 09, 2015 (BUSINESS WIRE) -- Tenax Therapeutics, Inc. TENX, +1.20% a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the ...
Tenax Therapeutics Announces Analyst Day and Webcast on April 13, 2015
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced that the company will ...
Tenax Therapeutics (TENX) Announces Quarterly Earnings Results, Misses ...
Tenax Therapeutics logo Tenax Therapeutics (NASDAQ:TENX) issued its quarterly earnings data on Thursday. The specialty pharmaceutical company reported ($0.18) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.14) by $0.04 ...
Tenax Therapeutics (TENX) Releases Earnings Results, Misses Expectations By ...  sleekmoney
Stock Runners: Universal Forest Products Inc. (NASDAQ:UFPI), Tenax ...  Stock Transcript
Tenax Therapeutics Provides Clinical and Corporate Update
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today provided an update regarding ...
Tenax Therapeutics Spotlights Academic Publication on Levosimendan in Cardiac ...
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today highlighted a recently-published ...
Tenax Therapeutics Announces First Quarter Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), formerly Oxygen Biotherapeutics, Inc., a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, ...
Tenax Therapeutics' (TENX) CEO John Kelley on Q1 2015 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Form 4 TENAX THERAPEUTICS, INC. For: May 01 Filed by: Jebsen Michael B
... SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549. STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of ...
Tenax Therapeutics Announces Fourth Quarter and Fiscal Year 2015 Financial Results
MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (NASDAQ: TENX), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for ...